DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Household
Updated 1h ago
SNYR.Q logo

Synergy CHC Corp.OTCPK:SNYR.Q Stock Report

Market Cap US$804.6k
Updated 1h ago
Share Price
n/a
1Y-97.9%
7D-40.7%
1D-40.3%
Portfolio Value
​
View

Synergy CHC Corp.

OTCPK:SNYR.Q Stock Report

Market Cap: US$804.6k

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Synergy CHC (SNYR.Q) Stock Overview

Provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. More details

SNYR.Q fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Rewards

Revenue is forecast to grow 14.94% per year

Trading at good value compared to peers and industry

Risk Analysis

Negative shareholders equity

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap ($805K)

Highly volatile share price over the past 3 months compared to the US market

+ 1 more risk

SNYR.Q Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
98.6% undervalued intrinsic discount
AnalystConsensusTarget
•2mo ago

Brain Health And Clean Energy Trends Will Support Long Term Undervaluation Thesis

23
0
1
AN
AnalystLowTarget
98.9% undervalued intrinsic discount
AnalystLowTarget
•6mo ago

Cautious On Beverage Rollout And DSD Costs Yet Expecting Healthier Margins Ahead

13
0
0
AN
AnalystHighTarget
99.2% undervalued intrinsic discount
AnalystHighTarget
•7mo ago

Rapid Retail Expansion And Direct Store Distribution Will Transform Long Term Earnings Power

16
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
98.6% undervalued intrinsic discount
AnalystConsensusTarget
•2mo ago

Brain Health And Clean Energy Trends Will Support Long Term Undervaluation Thesis

23
0
1
AN
AnalystLowTarget
98.9% undervalued intrinsic discount
AnalystLowTarget
•6mo ago

Cautious On Beverage Rollout And DSD Costs Yet Expecting Healthier Margins Ahead

13
0
0
AN
AnalystHighTarget
99.2% undervalued intrinsic discount
AnalystHighTarget
•7mo ago

Rapid Retail Expansion And Direct Store Distribution Will Transform Long Term Earnings Power

16
0
0
View all narratives

Synergy CHC Corp. Competitors

Nevis Brands

Symbol: OTCPK:NEVI.F
Market cap: US$634.6k

Skinvisible

Symbol: OTCPK:SKVI
Market cap: US$1.1m

LFTD Partners

Symbol: OTCPK:LIFD
Market cap: US$1.5m

BioAdaptives

Symbol: OTCPK:BDPT
Market cap: US$334.8k

Price History & Performance

Summary of share price highs, lows and changes for Synergy CHC
Historical stock prices
Current Share PriceUS$0.054
52 Week HighUS$2.96
52 Week LowUS$0.025
Beta0.64
1 Month Change-46.48%
3 Month Change-73.91%
1 Year Change-97.89%
3 Year Change-54.62%
5 Year Change-92.44%
Change since IPO-99.77%

Recent News & Updates

User avatar
Narrative Update • Jun 26

SNYR: Higher Discount Rate Will Shape Outlook Despite Nasdaq Listing Risk

Analysts have reset their price target on Synergy CHC to $3.75 from $6, reflecting a higher $12.46 discount rate, more conservative forecasts for revenue growth and profit margins, and a higher assumed future P/E of 35.70 based on recent sector research trends. Analyst Commentary Street research around the broader specialty pharma and biotech space gives some useful context for how analysts might be thinking about Synergy CHC, especially when it comes to execution risk, research outcomes, and how those factors can feed into valuation multiples and discount rates.

Recent updates

User avatar
Narrative Update • Jun 26

SNYR: Higher Discount Rate Will Shape Outlook Despite Nasdaq Listing Risk

Analysts have reset their price target on Synergy CHC to $3.75 from $6, reflecting a higher $12.46 discount rate, more conservative forecasts for revenue growth and profit margins, and a higher assumed future P/E of 35.70 based on recent sector research trends. Analyst Commentary Street research around the broader specialty pharma and biotech space gives some useful context for how analysts might be thinking about Synergy CHC, especially when it comes to execution risk, research outcomes, and how those factors can feed into valuation multiples and discount rates.
User avatar
New Narrative • Mar 05

Cautious On Beverage Rollout And DSD Costs Yet Expecting Healthier Margins Ahead

Catalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Feb 17

Brain Health And Clean Energy Trends Will Support Long Term Undervaluation Thesis

Catalysts About Synergy CHC Synergy CHC develops and sells FOCUSfactor branded brain health supplements and functional beverages across retail, convenience and international channels. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Feb 03

Rapid Retail Expansion And Direct Store Distribution Will Transform Long Term Earnings Power

Catalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional energy and brain health beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?
Analysis Article • Jan 28

Investors Aren't Buying Synergy CHC Corp.'s (NASDAQ:SNYR) Earnings

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...
Analysis Article • Nov 20

Should You Think About Buying Synergy CHC Corp. (NASDAQ:SNYR) Now?

Synergy CHC Corp. ( NASDAQ:SNYR ), is not the largest company out there, but it saw a decent share price growth of 18...
Analysis Article • Aug 27

Synergy CHC's (NASDAQ:SNYR) Problems Go Beyond Poor Profit

Synergy CHC Corp.'s ( NASDAQ:SNYR ) lackluster earnings announcement last week disappointed investors. We think that...

Shareholder Returns

SNYR.QUS Personal ProductsUS Market
7D-40.7%-2.5%-0.1%
1Y-97.9%-4.7%11.9%

Return vs Industry: SNYR.Q underperformed the US Personal Products industry which returned -4.7% over the past year.

Return vs Market: SNYR.Q underperformed the US Market which returned 11.9% over the past year.

Price Volatility

Is SNYR.Q's price volatile compared to industry and market?
SNYR.Q volatility
SNYR.Q Average Weekly Movement73.9%
Personal Products Industry Average Movement9.0%
Market Average Movement6.8%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market2.9%

Stable Share Price: SNYR.Q's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: SNYR.Q's weekly volatility has increased from 38% to 74% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201028Jack Rosssynergychc.com

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug.

Synergy CHC Corp. Fundamentals Summary

How do Synergy CHC's earnings and revenue compare to its market cap?
SNYR.Q fundamental statistics
Market capUS$804.59k
Earnings (TTM)-US$15.79m
Revenue (TTM)US$27.70m
0.0x
P/S Ratio
-0.1x
P/E Ratio

Is SNYR.Q overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SNYR.Q income statement (TTM)
RevenueUS$27.70m
Cost of RevenueUS$9.59m
Gross ProfitUS$18.11m
Other ExpensesUS$33.90m
Earnings-US$15.79m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-1.06
Gross Margin65.37%
Net Profit Margin-56.98%
Debt/Equity Ratio-109.2%

How did SNYR.Q perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 08:34
End of Day Share Price 2026/09/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Synergy CHC Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide